Clinical Trial Update: A Study of PF-07260437 in Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 study of PF-07260437 in advanced or metastatic solid tumors was terminated, with results posted on 2025-05-06.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Endometrial Cancer
• Ovarian Cancer

Drugs mentioned

• PF-07260437 (PF-07260437)

Snippet

Sponsor: Pfizer | Conditions: Ovarian Neoplasms, Endometrial Neoplasms | Phase 1 | Status: TERMINATED | Results posted: 2025-05-06